[Angiotensin II-receptor antagonists compared to other antihypertensives: still insufficient evidence for reducing the risk of cerebrovascular incidents]

Ned Tijdschr Geneeskd. 2008 Jan 12;152(2):71-5.
[Article in Dutch]

Abstract

--There is growing evidence that angiotensin II-receptor antagonists may have protective effects for preventing cerebrovascular incidents. --It is unlikely that these effects are due only to a decrease in blood pressure. --One hypothesis is that high concentrations ofangiotensin II result in improved cerebral perfusion ofangiotensin type 2-receptor mediated mechanisms such as local vasodilatation and angiogenesis. --Several clinical and preclinical studies support this hypothesis. --The results of these studies are discussed in this overview. There is still insufficient evidence that a protective effect on the brain occurs.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / pharmacology*
  • Angiotensin II Type 2 Receptor Blockers*
  • Antihypertensive Agents / pharmacology*
  • Humans
  • Hypertension / physiopathology
  • Renin-Angiotensin System / drug effects
  • Renin-Angiotensin System / physiology
  • Risk Factors
  • Stroke / epidemiology
  • Stroke / prevention & control*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin II Type 2 Receptor Blockers
  • Antihypertensive Agents